{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:37:30Z","timestamp":1790422650084,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.imlet.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T05:06:16Z","timestamp":1515128776000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Pathogenic roles of B lymphocytes in systemic sclerosis"],"prefix":"10.1016","volume":"195","author":[{"given":"Ayumi","family":"Yoshizaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2018.01.002_bib0005","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"issue":"Suppl. 8","key":"10.1016\/j.imlet.2018.01.002_bib0010","first-page":"53","article-title":"Hypothesis for the pathogenesis of systemic sclerosis","volume":"24","author":"Furst","year":"1997","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ard.2009.121053","article-title":"Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation","volume":"70","author":"Yoshizaki","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2018.01.002_bib0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10875-008-9252-x","article-title":"Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity","volume":"29","author":"Yoshizaki","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0025","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","article-title":"Antinuclear antibody in systemic sclerosis (scleroderma)","volume":"22","author":"Okano","year":"1996","journal-title":"Rheum. Dis. Clin. N. Am."},{"key":"10.1016\/j.imlet.2018.01.002_bib0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molimm.2004.06.025","article-title":"Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis","volume":"41","author":"Sato","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0040","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.40164","article-title":"Contribution of soluble forms of programmed death 1 and programmed death ligand 2 to disease severity and progression in systemic sclerosis","volume":"69","author":"Fukasawa","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0045","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.01.002_bib0050","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1073\/pnas.93.6.2264","article-title":"Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires","volume":"93","author":"Goodnow","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.01.002_bib0055","first-page":"59","article-title":"Polyclonal B lymphocyte activation in progressive systemic sclerosis","volume":"29","author":"Famularo","year":"1989","journal-title":"J. Clin. Lab. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0060","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/art.1780200410","article-title":"Cellular infiltrates in scleroderma skin","volume":"20","author":"Fleischmajer","year":"1977","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000082087","article-title":"The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system","volume":"8","author":"Tedder","year":"2005","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.imlet.2018.01.002_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/art.21526","article-title":"Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes","volume":"54","author":"Matsushita","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2018.01.002_bib0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2010.00991.x","article-title":"Novel regulatory functions for Toll-like receptor-activated B cells during intracellular bacterial infection","volume":"240","author":"Fillatreau","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2018.01.002_bib0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.coi.2010.10.009","article-title":"Regulation of immunity and autoimmunity by B cells","volume":"22","author":"Mauri","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0090","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2018.01.002_bib0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.imlet.2018.01.002_bib0100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2018.01.002_bib0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00646.x","article-title":"B-lymphocyte contributions to human autoimmune disease","volume":"223","author":"Yanaba","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2018.01.002_bib0110","first-page":"3420","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2018.01.002_bib0115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/rheumatology\/kev331","article-title":"Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity","volume":"55","author":"Matsushita","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2018.01.002_bib0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-065X.2008.00661.x","article-title":"Regulatory B cells as inhibitors of immune responses and inflammation","volume":"224","author":"Bouaziz","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.imlet.2018.01.002_bib0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1346-8138.13184","article-title":"B lymphocytes in systemic sclerosis: abnormalities and therapeutic targets","volume":"43","author":"Yoshizaki","year":"2016","journal-title":"J. Dermatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2015.27.1.1","article-title":"Abnormal B lymphocyte activation and function in systemic sclerosis","volume":"27","author":"Yoshizaki","year":"2015","journal-title":"Ann. Dermatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/smim.1998.0118","article-title":"Introduction: response-regulators of B lymphocyte signaling thresholds provide a context for antigen receptor signal transduction","volume":"10","author":"Tedder","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1074-7613(00)80418-5","article-title":"The CD19\/21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity","volume":"6","author":"Tedder","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2018.01.002_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)00027-3","article-title":"Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis","volume":"13","author":"Bolland","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2018.01.002_bib0150","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0092-8674(00)00209-9","article-title":"An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity","volume":"103","author":"Majeti","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2018.01.002_bib0155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1074-7613(00)80124-7","article-title":"CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation","volume":"11","author":"Pan","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2018.01.002_bib0160","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1084\/jem.186.11.1923","article-title":"CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes","volume":"186","author":"Inaoki","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2018.01.002_bib0165","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.4049\/jimmunol.157.10.4371","article-title":"CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity","volume":"157","author":"Sato","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1074-7613(00)80270-8","article-title":"CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice","volume":"5","author":"Sato","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2018.01.002_bib0175","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1126\/science.274.5288.798","article-title":"Hyperresponsive B cells in CD22-deficient mice","volume":"274","author":"O\u2019Keefe","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.imlet.2018.01.002_bib0180","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0167-5699(94)90274-7","article-title":"The CD19\/CD21 signal transduction complex of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.imlet.2018.01.002_bib0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/1074-7613(95)90157-4","article-title":"Abnormal B lymphocyte development, activation and differentiation in mice that lack or overexpress the CD19 signal transduction molecule","volume":"3","author":"Engel","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2018.01.002_bib0190","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/376352a0","article-title":"Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice","volume":"376","author":"Rickert","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2018.01.002_bib0195","doi-asserted-by":"crossref","first-page":"11558","DOI":"10.1073\/pnas.92.25.11558","article-title":"The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation","volume":"92","author":"Sato","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.01.002_bib0200","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.4049\/jimmunol.158.10.4662","article-title":"CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19","volume":"158","author":"Sato","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0205","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1128\/MCB.14.6.3884","article-title":"Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B lymphocyte development","volume":"14","author":"Zhou","year":"1994","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0210","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0215","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/art.20274","article-title":"Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells","volume":"50","author":"Sato","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0220","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/01.bor.0000179945.73518.28","article-title":"B lymphocytes and systemic sclerosis","volume":"17","author":"Fujimoto","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/08830189909088489","article-title":"Expression and function of Fas during differentiation and activation of B cells","volume":"18","author":"Wang","year":"1999","journal-title":"Intern. Rev. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0230","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)63328-7","article-title":"B Lymphocyte signaling established by the CD19\/CD22 loop regulates autoimmunity in the tight-skin mouse","volume":"165","author":"Asano","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12079-017-0382-x","article-title":"B lymphocytes in renal interstitial fibrosis","volume":"11","author":"Zhu","year":"2017","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.imlet.2018.01.002_bib0240","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/hep.27761","article-title":"Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity","volume":"61","author":"Thapa","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.imlet.2018.01.002_bib0245","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI24798","article-title":"Attenuated liver fibrosis in the absence of B cells","volume":"115","author":"Novobrantseva","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2018.01.002_bib0250","doi-asserted-by":"crossref","first-page":"R168","DOI":"10.1186\/ar4352","article-title":"B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis","volume":"15","author":"Francois","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2018.01.002_bib0255","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.semarthrit.2014.09.002","article-title":"Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis","volume":"44","author":"Bosello","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0260","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.37738","article-title":"Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts","volume":"65","author":"H\u00fcgle","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0265","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0270","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","article-title":"Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6","volume":"97","author":"Duncan","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0275","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.185.3.461","article-title":"Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ t cells","volume":"185","author":"Rincon","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2018.01.002_bib0280","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1073\/pnas.89.13.6065","article-title":"Differential regulation of T helper phenotype development by interleukins 4 and 10 in an alpha beta T-cell-receptor transgenic system","volume":"89","author":"Hsieh","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.01.002_bib0285","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.30539","article-title":"Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0290","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI0215078","article-title":"CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse","volume":"109","author":"Saito","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2018.01.002_bib0295","doi-asserted-by":"crossref","first-page":"35466","DOI":"10.1074\/jbc.M206395200","article-title":"Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and \u2212independent pathways","volume":"277","author":"Lee","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2018.01.002_bib0300","doi-asserted-by":"crossref","first-page":"G1105","DOI":"10.1152\/ajpgi.00431.2001","article-title":"Endogenous interleukin-10 modulates fibrosis and regeneration in experimental chronic pancreatitis","volume":"282","author":"Demols","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0305","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2018.01.002_bib0310","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.4049\/jimmunol.151.9.4625","article-title":"Transforming growth factor-beta 1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro","volume":"151","author":"Snapper","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977199309029129","article-title":"Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta)","volume":"8","author":"Roberts","year":"1993","journal-title":"Growth Factors"},{"key":"10.1016\/j.imlet.2018.01.002_bib0320","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj2470597","article-title":"Transforming growth factor b (TGF b) causes a persistent increase in steady-state amounts for type I and III collagen and fibronectin mRNAs in normal human dermal fibroblasts","volume":"297","author":"Varga","year":"1987","journal-title":"Biochem. J."},{"key":"10.1016\/j.imlet.2018.01.002_bib0325","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0092-8674(00)81696-7","article-title":"Smads: transcriptional activators of TGF-beta responses","volume":"95","author":"Derynck","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2018.01.002_bib0330","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor b1: association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0335","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U","article-title":"Up-regulated expression of transforming growth factor b receptors in dermal fibroblasts in skin sections from patients with localized scleroderma","volume":"44","author":"Kubo","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0340","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0345","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","article-title":"PD-1 and PD-1 ligands: from discovery to clinical application","volume":"19","author":"Okazaki","year":"2007","journal-title":"Int. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0350","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.autrev.2010.04.003","article-title":"PD-1, gender, and autoimmunity","volume":"9","author":"Dinesh","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.imlet.2018.01.002_bib0355","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2018.01.002_bib0360","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/eji.200737461","article-title":"PD-L2 expression extends beyond dendritic cells\/macrophages to B1 cells enriched for V(H)11\/V(H)12 and phosphatidylcholine binding","volume":"37","author":"Zhong","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0365","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.01.002_bib0370","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/db09-1209","article-title":"Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia","volume":"59","author":"Yantha","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.imlet.2018.01.002_bib0375","first-page":"1015","article-title":"PD-1\/PD-L1, PD-1\/PD-L2, and other co-inhibitory signaling pathways in transplantation","volume":"21","author":"del Rio","year":"2008","journal-title":"Transpl. Int."},{"key":"10.1016\/j.imlet.2018.01.002_bib0380","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2018.01.002_bib0385","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ni.1877","article-title":"PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells","volume":"11","author":"Good-Jacobson","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0390","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","article-title":"The PD-1\/PD-Ls pathway and autoimmune diseases","volume":"290","author":"Dai","year":"2014","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0395","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.metabol.2012.12.005","article-title":"Increased PD-1 on CD4(+)CD28(\u2212) T cell and soluble PD-1 ligand-1 in patients with T2DM: association with atherosclerotic macrovascular diseases","volume":"62","author":"Shi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.imlet.2018.01.002_bib0400","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.4049\/jimmunol.177.12.8844","article-title":"Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis","volume":"177","author":"Wan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0405","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1101\/gr.6.4.300","article-title":"A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation","volume":"6","author":"Siracusa","year":"1996","journal-title":"Genome Res."},{"key":"10.1016\/j.imlet.2018.01.002_bib0410","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/BF03401821","article-title":"Induction of skin fibrosis in mice expressing a mutated fibrillin-1 gene","volume":"6","author":"Saito","year":"2000","journal-title":"Mol. Med."},{"key":"10.1016\/j.imlet.2018.01.002_bib0415","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/eji.1830240634","article-title":"A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice","volume":"24","author":"Wallace","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0420","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1073\/pnas.052709999","article-title":"Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-b production by fibroblasts","volume":"99","author":"Kodera","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2018.01.002_bib0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2005.03.013","article-title":"Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis","volume":"39","author":"Hasegawa","year":"2005","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.imlet.2018.01.002_bib0430","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0435","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.1999.00528.x","article-title":"Animal model of sclerotic skin. I: local injections of bleomycin induce sclerotic skin mimicking scleroderma","volume":"112","author":"Yamamoto","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0440","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00403-005-0635-z","article-title":"The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis","volume":"297","author":"Yamamoto","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.imlet.2018.01.002_bib0445","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/annrheumdis-2016-210189","article-title":"Inhibition of phosphodiesterase 4 (PDE4) reduces dermal fibrosis by interfering with the release of interleukin-6 from M2 macrophages","volume":"76","author":"Maier","year":"2017","journal-title":"Ann. Rheum Dis."},{"key":"10.1016\/j.imlet.2018.01.002_bib0450","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/rheumatology\/kel012","article-title":"Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis","volume":"45","author":"Ogawa","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.imlet.2018.01.002_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0300-483X(00)00272-9","article-title":"Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis","volume":"155","author":"Simonini","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.imlet.2018.01.002_bib0460","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00418-005-0116-7","article-title":"In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis","volume":"125","author":"Inghilleri","year":"2006","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0465","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1465-9921-6-11","article-title":"The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis","volume":"6","author":"Manoury","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.imlet.2018.01.002_bib0470","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carres.2006.10.027","article-title":"Inhibitory effects of different antioxidants on hyaluronan depolymerization","volume":"342","author":"Mendoza","year":"2007","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.imlet.2018.01.002_bib0475","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2353\/ajpath.2008.071049","article-title":"CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma","volume":"172","author":"Yoshizaki","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0480","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.cdd.4400460","article-title":"Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease","volume":"6","author":"Rosen","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.imlet.2018.01.002_bib0485","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1084\/jem.184.2.765","article-title":"Selective cleavage of nuclear autoantigens during CD95 (Fas\/APO-1)-mediated T cell apoptosis","volume":"184","author":"Casiano","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2018.01.002_bib0490","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI118851","article-title":"Endothelial cell apoptosis is a primary pathogeneic event underlying skin lesions in avian and human scleroderma","volume":"98","author":"Sgonc","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2018.01.002_bib0495","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.0022-202X.2003.22121.x","article-title":"Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma","volume":"122","author":"Yamamoto","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0500","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.24249","article-title":"B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis","volume":"60","author":"Lafyatis","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0505","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/annrheumdis-2013-204522","article-title":"Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group","volume":"74","author":"Jordan","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2018.01.002_bib0510","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar2965","article-title":"B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial","volume":"12","author":"Bosello","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.imlet.2018.01.002_bib0515","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.2008.095463","article-title":"Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study","volume":"69","author":"Smith","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2018.01.002_bib0520","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","article-title":"Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study","volume":"49","author":"Daoussis","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.imlet.2018.01.002_bib0525","first-page":"S17","article-title":"Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis","volume":"30","author":"Daoussis","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.imlet.2018.01.002_bib0530","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2018.01.002_bib0535","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817304303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T11:34:49Z","timestamp":1693395289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817304303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":107,"alternative-id":["S0165247817304303"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2018.01.002","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic roles of B lymphocytes in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}